GlassScriptPhysician profile
John R Massey
NPI 1922063528
$13,221.81
in general payments reported to CMS, 2019-2025
38 companies · $3,730 in 2025
The $3,730 reported for 2025 was more than what 91% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $696 · 2021: $917 · 2022: $1,367 · 2023: $1,451 · 2024: $4,607 · 2025: $3,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,782 · Travel and Lodging: $3,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,781.53 |
| Travel and Lodging | $3,006.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,477.64 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Saluda Medical Americas, INC. | $2,650.74 | 2024-2025 | Evoke |
| Medtronic, INC. | $1,120.20 | 2021-2024 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Abbvie INC. | $1,036.29 | 2021-2025 | |
| Si-Bone, INC. | $957.51 | 2021-2025 | |
| Abbott Laboratories | $340.06 | 2019-2024 | Proclaim, Eterna |
| Spr Therapeutics, INC | $329.69 | 2024-2025 | Sprint Pns System |
| Allergan, INC. | $221.80 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $208.82 | 2020-2025 | Belbuca, Xtampza |
| Biodelivery Sciences International, INC. | $199.29 | 2019-2021 | |
| Grt US Holding, INC. | $177.52 | 2021-2022 | |
| Mml US, INC. | $160.96 | 2023-2025 | Reactiv8 |
| Forte Bio-Pharma LLC | $124.48 | 2022-2024 | Prolate, Nalocet |
| Vertex Pharmaceuticals Incorporated | $120.54 | 2024-2025 | |
| Indivior INC. | $115.29 | 2019-2025 | Sublocade |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Massey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.